Back to Search

MARK MIROCHNICK, MD

MD

Neonatal-Perinatal Medicine Physician

NPI: 1508849969Individual

Specialties, Licenses & Credentials

Pediatrics Physician

Pediatrics

Code: 208000000X

51072(MA)
Neonatal-Perinatal Medicine PhysicianPrimary

Pediatrics — Neonatal-Perinatal Medicine

Code: 2080N0001X

51072(MA)

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

NCT01618305COMPLETEDPHASE4STUDY_CHAIR

Research & Publications (20)

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
PMID 32386720·Lancet HIV·2020
3-trial
Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
PMID 19114673·Antimicrob Agents Chemother·2009
8-other
Lopinavir exposure with an increased dose during pregnancy.
PMID 18989231·J Acquir Immune Defic Syndr·2008
3-trial
Nevirapine concentrations in newborns receiving an extended prophylactic regimen.
PMID 18398973·J Acquir Immune Defic Syndr·2008
3-trial
Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
PMID 17760737·HIV Med·2007
4-observational
Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life.
PMID 15905735·J Acquir Immune Defic Syndr·2005
3-trial
Pharmacokinetics of antiretrovirals in pregnant women.
PMID 15568888·Clin Pharmacokinet·2004
6-review
Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose.
PMID 12794547·J Acquir Immune Defic Syndr·2003
3-trial
Concentrations of protease inhibitors in cord blood after in utero exposure.
PMID 12352805·Pediatr Infect Dis J·2002
3-trial
Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.
PMID 11734746·Pediatr Infect Dis J·2001
3-trial
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.
PMID 11452241·Clin Pharmacol Ther·2001
3-trial
Antiretroviral pharmacology in pregnant women and their newborns.
PMID 11131716·Ann N Y Acad Sci·2000
8-other
Nevirapine: pharmacokinetic considerations in children and pregnant women.
PMID 11069214·Clin Pharmacokinet·2000
6-review
Bioequivalence of a propylene glycol-based liquid dapsone preparation and dapsone tablets.
PMID 11030029·Am J Health Syst Pharm·2000
8-other
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women.
PMID 19237646·Antimicrob Agents Chemother·2009
8-other
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum.
PMID 18795962·HIV Med·2008
4-observational
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics.
PMID 18366444·HIV Med·2008
4-observational
Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
PMID 17893155·Antimicrob Agents Chemother·2007
8-other
Reduced lopinavir exposure during pregnancy.
PMID 16988514·AIDS·2006
3-trial
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
PMID 16511414·AIDS·2006
2-rct

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
840 HARRISON AVE, MENINO 3
BOSTON, MA 02118

Location

Practice Location

840 HARRISON AVE, BOSTON, MA
(617) 414-5471

Quick Facts

NPI
1508849969
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Clinical Trials
1
Publications
20

Are you this provider?

Claim Your Profile